A2289 (2025-26 session)
NY State bill
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
- Title
- Enacts the manufacturer disclosure and transparency act
- Type
- New York State Assembly bill
- Session
- 2025-26 session
- Status
- In Assembly Committee
- Latest action date
- 2026-01-07
- In committee
- Consumer Affairs And Protection
- Introduced
- 2025-01-16
- Active version
- A2289A
- Same as
- S488
- Law section
- General Business Law
Sponsors
- Emily Gallagher Assembly Member, District 50
Co-sponsors
Heard in committee
- Consumer Affairs and Protection NY State Assembly committee
Same as
- S488 (2025-26 session) NY State bill